Page last updated: 2024-08-16

rivastigmine and sesquiterpenes

rivastigmine has been researched along with sesquiterpenes in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's2 (20.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Tang, XC; Zhao, Q1
Liang, YQ; Tang, XC2
Beck, C; Blank, K; Colenda, CC; Doraiswamy, MP; Kalunian, DA; Lyketsos, CG; Yaffe, K1
Tang, XC; Wang, J; Zhang, HY1
Adler, M; Akkerman, M; Albuquerque, EX; Aracava, Y; Pereira, EF1
Aisen, PS; Cummings, J; Schneider, LS1
Li, JJ; Ma, ZY; Yang, GL; Yang, Q; Zhang, YG1
Bai, LG; Cao, F; Han, C; Jian, MM; Ma, ZY; Xu, Y; Yang, K1
Abdel-Daim, MM; Akhtar, MF; Albadrani, GM; Arya, A; Chahal, R; El-Seedi, HR; Kamel, M; Kaushik, D; Khalifa, SMA; Mittal, V; Rahman, MH; Rao, R; Saleem, A1

Reviews

3 review(s) available for rivastigmine and sesquiterpenes

ArticleYear
Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.
    Acta pharmacologica Sinica, 2009, Volume: 30, Issue:7

    Topics: Acetylcholine; Alkaloids; Animals; Anti-Inflammatory Agents; Cholinergic Agents; Cholinesterase Inhibitors; Dementia, Vascular; Disease Models, Animal; Donepezil; Galantamine; Humans; Indans; Inflammation; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, Cholinergic; Rivastigmine; Sesquiterpenes; Signal Transduction

2009
Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.
    Cold Spring Harbor perspectives in medicine, 2012, Volume: 2, Issue:3

    Topics: Alkaloids; Alzheimer Disease; Amino Acids; Animals; Cholinesterase Inhibitors; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Donepezil; Drug Approval; Galantamine; Ginkgo biloba; Half-Life; History, 20th Century; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Psychotropic Drugs; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Sesquiterpenes; Vitamin B Complex; Vitamin E

2012
Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy.
    Biomolecules, 2021, 02-25, Volume: 11, Issue:3

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Galantamine; Humans; Rivastigmine; Sesquiterpenes

2021

Other Studies

7 other study(ies) available for rivastigmine and sesquiterpenes

ArticleYear
Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.
    European journal of pharmacology, 2002, Nov-29, Volume: 455, Issue:2-3

    Topics: Acetylcholinesterase; Alkaloids; Animals; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Corpus Striatum; Donepezil; Hippocampus; Indans; Isoenzymes; Kinetics; Male; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Sprague-Dawley; Rivastigmine; Sesquiterpenes; Tacrine

2002
Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
    Neuroscience letters, 2004, May-06, Volume: 361, Issue:1-3

    Topics: Acetylcholine; Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Brain Chemistry; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Fasciculation; Indans; Male; Neurons; Phenylcarbamates; Piperidines; Rats; Rats, Sprague-Dawley; Rivastigmine; Sesquiterpenes; Up-Regulation

2004
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:7

    Topics: Aged; Alkaloids; Alzheimer Disease; Brain; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Galantamine; Geriatric Psychiatry; Health Services for the Aged; Humans; Phenylcarbamates; Professional-Family Relations; Rivastigmine; Sesquiterpenes; Tacrine; United States

2006
Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
    Acta pharmacologica Sinica, 2006, Volume: 27, Issue:9

    Topics: Acetylcholine; Administration, Oral; Alkaloids; Animals; Brain; Cholinesterase Inhibitors; Donepezil; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Indans; Male; Neuroprotective Agents; Norepinephrine; Phenylcarbamates; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Rivastigmine; Serotonin; Sesquiterpenes

2006
Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:3

    Topics: Acetylcholinesterase; Alkaloids; Animals; Antidotes; Chemical Warfare Agents; Donepezil; Dose-Response Relationship, Drug; Galantamine; Guinea Pigs; Indans; Lethal Dose 50; Male; Phenylcarbamates; Piperidines; Poisoning; Rivastigmine; Sesquiterpenes; Soman; Time Factors; Toxicity Tests, Acute

2009
[Design, synthesis and evaluation of N-acyl-4-phenylthiazole-2-amines as acetylcholinesterase inhibitors].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2014, Volume: 49, Issue:6

    Topics: Acetylcholinesterase; Alkaloids; Amines; Cholinesterase Inhibitors; Drug Design; Rivastigmine; Sesquiterpenes; Structure-Activity Relationship; Thiazoles

2014
Design, synthesis and evaluation of new 4-arylthiazole-2-amine derivatives as acetylcholinesterase inhibitors.
    Bioorganic & medicinal chemistry letters, 2020, 03-15, Volume: 30, Issue:6

    Topics: Acetylcholinesterase; Alkaloids; Amines; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Humans; Molecular Docking Simulation; Neuroprotective Agents; Rivastigmine; Sesquiterpenes; Structure-Activity Relationship; Thiazoles

2020